Our Company

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
NASDAQ: TNDM
Price:
$2.45
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on Feb 24, 2017

View all »   RSSRecent Releases

Feb 21, 2017
Tandem Diabetes Care Schedules Fourth Quarter and Full Year 2016 Earnings Press Release and Conference Call

Feb 15, 2017
Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump (SAP) over Medtronic MiniMed SAPs

View all »Events & Presentations

Mar 8, 2017 at 1:30 PM PT
Q4 Tandem Diabetes Care 2016 Earnings